Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series

This study was to investigate the efficacy and safety of fulvestrant 500 mg for the treatment of hormone receptor positive advanced postmenopausal women, including ovarian ablation and investigated factors associated with prolonged time-to-treatment failure. Data from 60 women with metastatic breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jian, Huang, Ping, Shao, Xi-ying, Sun, Yan, Lei, Lei, Lou, Cai-jin, Ye, Wei-wu, Chen, Jun-qing, Cao, Wen-ming, Huang, Yuan, Zheng, Ya-bing, Wang, Xiao-jia, Chen, Zhan-hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373621/
https://www.ncbi.nlm.nih.gov/pubmed/32702824
http://dx.doi.org/10.1097/MD.0000000000020821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373621/
https://www.ncbi.nlm.nih.gov/pubmed/32702824
http://dx.doi.org/10.1097/MD.0000000000020821

Ejemplares similares